Skip to main content

CorMedix Inc.

CRMD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001410098

No open-market purchases or sales by CorMedix Inc. insiders were filed in the last 90 days; 193 institutions reported holding it in 13F filings for Q2 2026, worth $345.5M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by CorMedix Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for CorMedix Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for CorMedix Inc.
NameTitleLast reported holdingLast filingFilings, past year
Dillione JanetDirector117,835Sep 18, 20267
Blum SusanChief Financial Officer124,315Sep 1, 20262
Masson-Hurlburt ElizabethChief Operating Officer270,463Sep 1, 20265
Zelnick Kaufman BethChief Legal Officer260,684Sep 1, 20264
Todisco JosephChief Executive Officer774,749Feb 6, 20264
Dunton Alan WDirector70,703Jan 27, 20262
Lefkowitz Steven WDirector125,951Jan 27, 20263
Stewart Robert ADirector66,453Jan 27, 20261
Kaplan MyronDirector231,487Jan 27, 20262
Duncan Gregory ScottDirector68,786Jan 27, 20261
Seckler Michael DavidChief Commercial Officer133,156Jan 15, 20261
David Matthew TChief Financial Officer95,270Jan 14, 20250
Mistry ErinEVP, Chief Commercial Officer100,992Jan 14, 20250
Costa Paulo FDirector10,000May 18, 20230
Mounts PhoebeGeneral Counsel–Jan 18, 20230
Nusbickel ThomasEVP, Chief Commercial Officer–Feb 23, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jan 22, 2026 (view filing)Jan 211 dayDillione JanetDirectorSSale−10.0K$6.88−$68.8K−20.6%38.5K after10b5-1
Jan 2, 2026 (view filing)Dec 30, 20253 daysDunton Alan WDirectorSSale−20.0K$13.00−$260.0K−33.2%40.3K after10b5-1
Dec 19, 2025 (view filing)Dec 181 dayTodisco JosephChief Executive OfficerSSale−30.0K$12.00−$360.0K−5.6%509.5K after10b5-1
Dec 11, 2025 (view filing)Dec 92 daysDillione JanetDirectorSSale−34.0K$12.00−$408.0K−41.2%48.5K after10b5-1
Dec 10, 2025 (view filing)Dec 91 dayLefkowitz Steven WDirectorSSale−40.0K$11.88−$475.2K−33.2%80.5K after
Dec 4, 2025 (view filing)Dec 22 daysDillione JanetDirectorSSale−46.7K$10.00−$466.6K−49.0%48.5K after10b5-1
Nov 26, 2025 (view filing)Nov 242 daysDillione JanetDirectorSSale−26.3K$9.93−$261.6K−35.2%48.5K after
Nov 18, 2025 (view filing)Nov 144 daysDillione JanetDirectorSSale−30.0K$11.42−$342.6K−38.2%48.5K after
Oct 27, 2025 (view filing)Oct 234 daysKaplan MyronDirectorPPurchase+25.0K$11.02+$275.5K+14.2%201.0K after
Sep 16, 2025 (view filing)Sep 124 daysDunton Alan WDirectorSSale−10.0K$13.13−$131.3K−19.9%40.3K after
Sep 12, 2025 (view filing)Sep 12Same dayTodisco JosephChief Executive OfficerSSale−50.0K$13.00−$650.0K−8.9%509.5K after
Sep 11, 2025 (view filing)Sep 92 daysZelnick Kaufman BethChief Legal OfficerSSale−50.0K$13.41−$670.3K−21.7%180.4K after2 lots
Sep 11, 2025 (view filing)Sep 9-112 daysMasson-Hurlburt ElizabethChief Operating OfficerSSale−54.0K$13.18−$711.8K−23.4%177.0K after2 lots
Dec 13, 2024 (view filing)Oct 3143 daysLateMistry ErinEVP, Chief Commercial OfficerPPurchase+1.50K$9.99+$15.0K+3.0%52.0K after
Nov 18, 2024 (view filing)Nov 144 daysMasson-Hurlburt ElizabethEVPSSale−140.0K$11.18−$1.57M−75.5%45.4K after
Mar 14, 2024 (view filing)Mar 131 dayTodisco JosephChief Executive OfficerPPurchase+13.6K$3.74+$50.7K+4.0%352.8K after
Dec 18, 2023 (view filing)Dec 14-154 daysDunton Alan WDirectorPPurchase+6.00K$3.38+$20.3K+64.9%15.3K after2 lots
Nov 21, 2023 (view filing)Nov 174 daysMistry ErinChief Commercial OfficerPPurchase+1.00K$4.00+$4.00K+25.6%4.90K after
Sep 8, 2023 (view filing)Sep 8Same dayTodisco JosephChief Executive OfficerPPurchase+10.0K$3.71+$37.1K+4.8%219.7K after
May 19, 2023 (view filing)May 181 dayKaplan MyronDirectorPPurchase+6.00K$4.54+$27.2K+3.7%166.0K after
May 18, 2023 (view filing)May 171 dayCosta Paulo FDirectorPPurchase+10.0K$4.65+$46.5KNew position10.0K afterAmended
May 18, 2023 (view filing)May 171 dayDunton Alan WDirectorPPurchase+3.00K$4.33+$13.0K+48.0%9.25K afterAmended
May 18, 2023 (view filing)May 171 dayStewart Robert ADirectorPPurchase+10.0K$4.37+$43.7K+1,000.0%11.0K afterAmended
May 18, 2023 (view filing)May 171 dayTodisco JosephChief Executive OfficerPPurchase+5.00K$4.58+$22.9K+2.4%209.7K afterAmended
Nov 16, 2022 (view filing)Nov 151 dayTodisco JosephChief Executive OfficerPPurchase+20.0K$3.82+$76.4K+9.0%242.2K after
Aug 25, 2022 (view filing)Aug 241 dayTodisco JosephChief Executive OfficerPPurchase+4.70K$3.92+$18.4K+2.2%222.2K after
May 18, 2022 (view filing)May 171 dayKaplan MyronDirectorPPurchase+5.00K$3.78+$18.9K+3.2%160.0K after
May 17, 2022 (view filing)May 161 dayTodisco JosephChief Executive OfficerPPurchase+10.0K$3.38+$33.8K+4.8%217.5K after
Dec 7, 2021 (view filing)Dec 61 dayDavid Matthew TInterim CEO and CFOPPurchase+1.00K$4.50+$4.50K+46.5%3.15K afterDuplicate filing
Dec 7, 2021 (view filing)Dec 61 dayDavid Matthew TInterim CEO and CFOPPurchase+1.00K$4.50+$4.50K+46.5%3.15K after
Nov 19, 2021 (view filing)Nov 163 daysLateKaplan MyronDirectorPPurchase+10.0K$5.14+$51.4K+6.1%175.0K after
Nov 19, 2021 (view filing)Nov 172 daysDavid Matthew TInterim CEO and CFOPPurchase+1.00K$5.07+$5.07K+87.0%2.15K after